Search

Abt has extensive experience investigating and addressing the complex effects of per- and polyfluoroalkyl substances (PFAS) in the environment and on human health.

The Department of Health and Human Services (HHS) wanted to determine if teen pregnancy prevention programs with limited prior evidence of effectiveness can work when replicated with different populations and in different settings. HHS contracted with…

Older adults are among those with the highest risk for medically attended COVID-19. From early in the COVID-19 pandemic, CDC needed data to characterize risk factors and clinical epidemiology of COVID-19 among older adults. The information would inform…

The Institute of Education Sciences’ What Works Clearinghouse wanted a systematic review of evidence on interventions designed to improve the social, emotional, and behavioral outcomes of students in kindergarten to grade 12. Abt Global and our partners…

As the COVID-19 pandemic unfolded, HPOG 2.0 programs adapted their procedures to continue activities while protecting their staff, students, and partners.

AHRQ enlisted Abt Global and IMPAQ to develop MHCSIII to improve patient safety; four journal articles by Abt staff were generated by the project.

The Centers for Medicare & Medicaid Services created the Cell and Gene Therapy Access Model to be able to negotiate with manufacturers on behalf of states to make high-cost specialty drugs available to beneficiaries and affordable to State Medicaid Agencies. 

The Abt-led USAID Integrated Health Program in the Democratic Republic of Congo is enhancing the ability of communities to combat tuberculosis.